These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 18278759)

  • 41. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The association between blood pressure and mortality in ESRD-not different from the general population?
    Lacson E; Lazarus JM
    Semin Dial; 2007; 20(6):510-7. PubMed ID: 17991196
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ambulatory blood pressure measurement in kidney transplantation: an overview.
    Tomson CR
    Transplantation; 2003 Dec; 76(11):1643-4. PubMed ID: 14702542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of home blood pressure measurement for preventing stroke and cardiovascular disease in hypertensive patients: a sub-analysis of the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
    Shimada K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimamoto K; Tanaka H; Yoshiike N
    Hypertens Res; 2008 Oct; 31(10):1903-11. PubMed ID: 19015598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic influence of office and ambulatory blood pressures in resistant hypertension.
    Salles GF; Cardoso CR; Muxfeldt ES
    Arch Intern Med; 2008 Nov; 168(21):2340-6. PubMed ID: 19029499
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    Blood Press Monit; 2008 Dec; 13(6):325-32. PubMed ID: 18756173
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients.
    Chan CT; Shen XS; Picton P; Floras J
    J Hypertens; 2008 Sep; 26(9):1795-800. PubMed ID: 18698214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Resistant hypertension in non-dialysis chronic kidney disease].
    Borrelli S; Minutolo R; Calabria M; Grimaldi M; Di Pietro R; Donnarumma G; D'Angio' PL; Conte G; De Nicola L
    G Ital Nefrol; 2009; 26(3):328-37. PubMed ID: 19554530
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic importance of white coat and masked hypertension].
    Gustavsen P; Hansen TW
    Ugeskr Laeger; 2009 Jun; 171(24):2019-22. PubMed ID: 19523366
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nocturnal blood pressure fall and metabolic syndrome score in patients with white coat hypertension.
    Vyssoulis G; Karpanou E; Adamopoulos D; Kyvelou SM; Gymnopoulou E; Cokkinos D; Stefanadis C
    Blood Press Monit; 2008 Oct; 13(5):251-6. PubMed ID: 18799949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M; Mann W; Derose S; Selevan D; Pascual N; Diesto J; Crooks P
    Am J Kidney Dis; 2009 Mar; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uric acid and nocturnal nondipping in hypertensive patients with normal renal function.
    Afsar B; Elsurer R; Ozdemir FN; Sezer S
    J Nephrol; 2008; 21(3):406-11. PubMed ID: 18587730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League.
    Lüders S; Schrader J; Berger J; Unger T; Zidek W; Böhm M; Middeke M; Motz W; Lübcke C; Gansz A; Brokamp L; Schmieder RE; Trenkwalder P; Haller H; Dominiak P;
    J Hypertens; 2008 Jul; 26(7):1487-96. PubMed ID: 18551027
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Relating cardiovascular risk to out-of-office blood pressure and the importance of controlling blood pressure 24 hours a day.
    White WB
    Am J Med; 2008 Aug; 121(8 Suppl):S2-7. PubMed ID: 18638615
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ambulatory blood pressure and cardiovascular risk in chronic kidney disease.
    Palatini P
    Curr Hypertens Rep; 2008 Apr; 10(2):119-26. PubMed ID: 18474178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Practical guide for interpretation and comprehension of ambulatory blood pressure measurement].
    Bibbo E; Muggli F; Pechère-Bertschi A
    Rev Med Suisse; 2008 Sep; 4(170):1910, 1912-6. PubMed ID: 18847119
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Masked hypertension determined by self-measured blood pressure at home and chronic kidney disease in the Japanese general population: the Ohasama study.
    Terawaki H; Metoki H; Nakayama M; Ohkubo T; Kikuya M; Asayama K; Inoue R; Hoshi H; Ito S; Imai Y
    Hypertens Res; 2008 Dec; 31(12):2129-35. PubMed ID: 19139602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Masked hypertension: subtypes and target organ damage.
    Kawano Y; Horio T; Matayoshi T; Kamide K
    Clin Exp Hypertens; 2008 Apr; 30(3):289-96. PubMed ID: 18425708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
    Levin A; Djurdjev O; Beaulieu M; Er L
    Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.